Gencler, Onur SerdarGencler, BilgenAltunel, Cemile TugbaArslan, Nur2025-10-242025-10-2420151319-01642213-7475https://doi.org/10.1016/j.jsps.2015.02.010https://hdl.handle.net/20.500.12899/3461Levetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. Here we report the case of psoriasiform drug eruption in a patient with newly diagnosed epilepsy who had been treated with levetiracetam. To our knowledge this is the first report of a patient with a psoriasiform eruption that appeared after the administration of LEV. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.eninfo:eu-repo/semantics/openAccessLevetiracetam; Epilepsy; Psoriasiform drug eruptionArticle10.1016/j.jsps.2015.02.010236720722267022692-s2.0-84952871765Q2WOS:000365833800017Q3